Shan, Yan-Shen

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J. F., et al. (2016) · The Lancet

Pancreatic and Hepatic Oncology ResearchCancer Treatment and Pharmacology

Cited by 1,222

P-124 Nivolumab plus ipilimumab as neoadjuvant therapy for potentially resectable hepatocellular carcinoma

Su, Y., Lin, Y., Hsiao, C., Ou, D., Chen, S., Wu, Y., Lee, W., Lin, J., Hsu, C., Ho, M., et al. (2021) · Annals of Oncology

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 11

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats

Yu, H.-H., Hsieh, M.-C., Wu, S.-Y., Sy, E. D., & Shan, Y.-S. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Bariatric Surgery and OutcomesLiver Disease Diagnosis and Treatment

Cited by 9

Second harmonic generation microscopy reveals the spatial orientation of glutamine-potentiated liver regeneration after hepatectomy

Yen, C.-C., Yen, C.-S., Tsai, H.-W., Yeh, M. M., Hong, T.-M., Wang, W.-L., Liu, I.-T., Shan, Y.-S., & Yen, C.-J. (2025) · Hepatology Communications

Liver physiology and pathologyTissue Engineering and Regenerative Medicine

Cited by 4